NASDAQ · AIRSHealthcareOffices & Clinics — Doctors

AirSculpt Technologies financials

$1.80−4.26%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
Revenue$151.8M$180.3M$195.9M$168.8M$133.3M
Gross profit$90.1M$109.2M$122.1M$106.0M$88.8M
Gross margin59.4%60.5%62.3%62.8%66.6%
Operating income-$9.4M-$1.6M$9.7M-$3.5M$15.8M
Net income-$11.7M-$8.0M-$4.2M-$14.7M-$393.0K
Net margin−7.7%−4.4%−2.2%−8.7%−0.3%
Diluted EPS$-0.19$-0.14$-0.08$-0.26$-0.01
EBITDA$7.9M$10.3M$19.8M$4.6M$23.0M
Operating cash flow$3.1M$11.3M$24.0M$24.4M$26.6M
Free cash flow$692.0K-$2.7M$14.0M$11.5M$19.5M
Diluted shares60.5M57.7M56.8M55.7M55.6M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$8.4M$8.2M$10.3M$9.6M$25.3M
Short-term investments$0.00$0.00$0.00$0.00—
Total debt$56.0M$74.7M$71.6M$83.5M$82.6M
Total assets$187.3M$212.8M$204.0M$200.8M$200.6M
Total liabilities$99.6M$134.6M$120.0M$130.0M$117.0M
Shareholders' equity$87.7M$78.2M$84.0M$70.8M$83.5M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology